nodes	percent_of_prediction	percent_of_DWPC	metapath
Edrophonium—BCHE—diaphragm—ovarian cancer	0.272	0.531	CbGeAlD
Edrophonium—BCHE—myometrium—ovarian cancer	0.033	0.0646	CbGeAlD
Edrophonium—ACHE—testis—ovarian cancer	0.0316	0.0618	CbGeAlD
Edrophonium—BCHE—uterine cervix—ovarian cancer	0.0257	0.0503	CbGeAlD
Edrophonium—BCHE—endometrium—ovarian cancer	0.0232	0.0455	CbGeAlD
Edrophonium—ACHE—lymph node—ovarian cancer	0.0229	0.0448	CbGeAlD
Edrophonium—Convulsion—Altretamine—ovarian cancer	0.022	0.0456	CcSEcCtD
Edrophonium—BCHE—uterus—ovarian cancer	0.0214	0.0419	CbGeAlD
Edrophonium—BCHE—female reproductive system—ovarian cancer	0.0193	0.0377	CbGeAlD
Edrophonium—BCHE—bone marrow—ovarian cancer	0.0182	0.0356	CbGeAlD
Edrophonium—BCHE—vagina—ovarian cancer	0.0174	0.0341	CbGeAlD
Edrophonium—BCHE—testis—ovarian cancer	0.0155	0.0304	CbGeAlD
Edrophonium—Asthenia—Altretamine—ovarian cancer	0.0148	0.0308	CcSEcCtD
Edrophonium—Vomiting—Altretamine—ovarian cancer	0.0132	0.0273	CcSEcCtD
Edrophonium—Dysphonia—Paclitaxel—ovarian cancer	0.0128	0.0266	CcSEcCtD
Edrophonium—Cardiac arrest—Topotecan—ovarian cancer	0.0127	0.0263	CcSEcCtD
Edrophonium—Cardiac arrest—Melphalan—ovarian cancer	0.0124	0.0257	CcSEcCtD
Edrophonium—Nausea—Altretamine—ovarian cancer	0.0123	0.0255	CcSEcCtD
Edrophonium—Lacrimation increased—Paclitaxel—ovarian cancer	0.0115	0.0238	CcSEcCtD
Edrophonium—BCHE—lymph node—ovarian cancer	0.0113	0.022	CbGeAlD
Edrophonium—Dysphagia—Vinorelbine—ovarian cancer	0.00984	0.0204	CcSEcCtD
Edrophonium—Lacrimation increased—Docetaxel—ovarian cancer	0.00971	0.0201	CcSEcCtD
Edrophonium—Paralysis—Epirubicin—ovarian cancer	0.00868	0.018	CcSEcCtD
Edrophonium—Arrhythmia—Melphalan—ovarian cancer	0.00806	0.0167	CcSEcCtD
Edrophonium—Paralysis—Doxorubicin—ovarian cancer	0.00804	0.0167	CcSEcCtD
Edrophonium—Convulsion—Chlorambucil—ovarian cancer	0.0078	0.0162	CcSEcCtD
Edrophonium—Dysphonia—Epirubicin—ovarian cancer	0.00733	0.0152	CcSEcCtD
Edrophonium—Cardiac arrest—Paclitaxel—ovarian cancer	0.00728	0.0151	CcSEcCtD
Edrophonium—Arrhythmia—Vinorelbine—ovarian cancer	0.00704	0.0146	CcSEcCtD
Edrophonium—Neostigmine—ABCB1—ovarian cancer	0.00695	1	CrCbGaD
Edrophonium—Convulsion—Melphalan—ovarian cancer	0.0068	0.0141	CcSEcCtD
Edrophonium—Dysphonia—Doxorubicin—ovarian cancer	0.00679	0.0141	CcSEcCtD
Edrophonium—Dysphagia—Paclitaxel—ovarian cancer	0.00662	0.0137	CcSEcCtD
Edrophonium—Lacrimation increased—Epirubicin—ovarian cancer	0.00655	0.0136	CcSEcCtD
Edrophonium—Sweating increased—Paclitaxel—ovarian cancer	0.00645	0.0134	CcSEcCtD
Edrophonium—Dysarthria—Epirubicin—ovarian cancer	0.00638	0.0132	CcSEcCtD
Edrophonium—Hyperhidrosis—Topotecan—ovarian cancer	0.00633	0.0131	CcSEcCtD
Edrophonium—Pollakiuria—Paclitaxel—ovarian cancer	0.00612	0.0127	CcSEcCtD
Edrophonium—Lacrimation increased—Doxorubicin—ovarian cancer	0.00606	0.0126	CcSEcCtD
Edrophonium—Hypotension—Melphalan—ovarian cancer	0.00599	0.0124	CcSEcCtD
Edrophonium—Dysarthria—Doxorubicin—ovarian cancer	0.0059	0.0123	CcSEcCtD
Edrophonium—Abdominal pain—Chlorambucil—ovarian cancer	0.00581	0.0121	CcSEcCtD
Edrophonium—Dysphagia—Docetaxel—ovarian cancer	0.00561	0.0116	CcSEcCtD
Edrophonium—Bradycardia—Paclitaxel—ovarian cancer	0.0054	0.0112	CcSEcCtD
Edrophonium—Asthenia—Chlorambucil—ovarian cancer	0.00527	0.0109	CcSEcCtD
Edrophonium—Hypotension—Vinorelbine—ovarian cancer	0.00523	0.0109	CcSEcCtD
Edrophonium—Abdominal pain—Topotecan—ovarian cancer	0.00517	0.0107	CcSEcCtD
Edrophonium—Diarrhoea—Chlorambucil—ovarian cancer	0.00503	0.0104	CcSEcCtD
Edrophonium—Arrhythmia—Paclitaxel—ovarian cancer	0.00473	0.00983	CcSEcCtD
Edrophonium—Asthenia—Topotecan—ovarian cancer	0.0047	0.00975	CcSEcCtD
Edrophonium—Vomiting—Chlorambucil—ovarian cancer	0.00467	0.0097	CcSEcCtD
Edrophonium—Asthenia—Melphalan—ovarian cancer	0.0046	0.00954	CcSEcCtD
Edrophonium—Diarrhoea—Topotecan—ovarian cancer	0.00448	0.00929	CcSEcCtD
Edrophonium—Abdominal pain—Vinorelbine—ovarian cancer	0.00443	0.00919	CcSEcCtD
Edrophonium—Diarrhoea—Melphalan—ovarian cancer	0.00438	0.0091	CcSEcCtD
Edrophonium—Diplopia—Epirubicin—ovarian cancer	0.00438	0.00909	CcSEcCtD
Edrophonium—Osteoarthritis—Epirubicin—ovarian cancer	0.00438	0.00909	CcSEcCtD
Edrophonium—Nausea—Chlorambucil—ovarian cancer	0.00437	0.00906	CcSEcCtD
Edrophonium—Cardiac arrest—Epirubicin—ovarian cancer	0.00416	0.00864	CcSEcCtD
Edrophonium—Vomiting—Topotecan—ovarian cancer	0.00416	0.00864	CcSEcCtD
Edrophonium—Vomiting—Melphalan—ovarian cancer	0.00407	0.00846	CcSEcCtD
Edrophonium—Osteoarthritis—Doxorubicin—ovarian cancer	0.00405	0.00841	CcSEcCtD
Edrophonium—Diplopia—Doxorubicin—ovarian cancer	0.00405	0.00841	CcSEcCtD
Edrophonium—Asthenia—Vinorelbine—ovarian cancer	0.00402	0.00834	CcSEcCtD
Edrophonium—Arrhythmia—Docetaxel—ovarian cancer	0.00401	0.00833	CcSEcCtD
Edrophonium—Convulsion—Paclitaxel—ovarian cancer	0.004	0.0083	CcSEcCtD
Edrophonium—Nausea—Topotecan—ovarian cancer	0.00389	0.00807	CcSEcCtD
Edrophonium—Cardiac arrest—Doxorubicin—ovarian cancer	0.00385	0.008	CcSEcCtD
Edrophonium—Diarrhoea—Vinorelbine—ovarian cancer	0.00383	0.00795	CcSEcCtD
Edrophonium—Nausea—Melphalan—ovarian cancer	0.00381	0.0079	CcSEcCtD
Edrophonium—Dysphagia—Epirubicin—ovarian cancer	0.00379	0.00786	CcSEcCtD
Edrophonium—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00364	0.00756	CcSEcCtD
Edrophonium—Vomiting—Vinorelbine—ovarian cancer	0.00356	0.00739	CcSEcCtD
Edrophonium—Hypotension—Paclitaxel—ovarian cancer	0.00352	0.0073	CcSEcCtD
Edrophonium—Dysphagia—Doxorubicin—ovarian cancer	0.0035	0.00727	CcSEcCtD
Edrophonium—Pollakiuria—Epirubicin—ovarian cancer	0.0035	0.00726	CcSEcCtD
Edrophonium—Convulsion—Docetaxel—ovarian cancer	0.00339	0.00703	CcSEcCtD
Edrophonium—Nausea—Vinorelbine—ovarian cancer	0.00333	0.0069	CcSEcCtD
Edrophonium—Pollakiuria—Doxorubicin—ovarian cancer	0.00324	0.00672	CcSEcCtD
Edrophonium—Bradycardia—Epirubicin—ovarian cancer	0.00308	0.0064	CcSEcCtD
Edrophonium—Hypotension—Docetaxel—ovarian cancer	0.00298	0.00619	CcSEcCtD
Edrophonium—Abdominal pain—Paclitaxel—ovarian cancer	0.00298	0.00618	CcSEcCtD
Edrophonium—Bradycardia—Doxorubicin—ovarian cancer	0.00285	0.00592	CcSEcCtD
Edrophonium—Arrhythmia—Epirubicin—ovarian cancer	0.00271	0.00562	CcSEcCtD
Edrophonium—Asthenia—Paclitaxel—ovarian cancer	0.0027	0.00561	CcSEcCtD
Edrophonium—Diarrhoea—Paclitaxel—ovarian cancer	0.00258	0.00535	CcSEcCtD
Edrophonium—Abdominal pain—Docetaxel—ovarian cancer	0.00252	0.00524	CcSEcCtD
Edrophonium—Arrhythmia—Doxorubicin—ovarian cancer	0.0025	0.0052	CcSEcCtD
Edrophonium—Vomiting—Paclitaxel—ovarian cancer	0.00239	0.00497	CcSEcCtD
Edrophonium—Asthenia—Docetaxel—ovarian cancer	0.00229	0.00475	CcSEcCtD
Edrophonium—Convulsion—Epirubicin—ovarian cancer	0.00229	0.00474	CcSEcCtD
Edrophonium—Nausea—Paclitaxel—ovarian cancer	0.00224	0.00464	CcSEcCtD
Edrophonium—Diarrhoea—Docetaxel—ovarian cancer	0.00218	0.00453	CcSEcCtD
Edrophonium—Convulsion—Doxorubicin—ovarian cancer	0.00211	0.00439	CcSEcCtD
Edrophonium—Hyperhidrosis—Epirubicin—ovarian cancer	0.00208	0.00432	CcSEcCtD
Edrophonium—Vomiting—Docetaxel—ovarian cancer	0.00203	0.00421	CcSEcCtD
Edrophonium—Hypotension—Epirubicin—ovarian cancer	0.00201	0.00418	CcSEcCtD
Edrophonium—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00193	0.004	CcSEcCtD
Edrophonium—Nausea—Docetaxel—ovarian cancer	0.0019	0.00393	CcSEcCtD
Edrophonium—Hypotension—Doxorubicin—ovarian cancer	0.00186	0.00386	CcSEcCtD
Edrophonium—Abdominal pain—Epirubicin—ovarian cancer	0.0017	0.00353	CcSEcCtD
Edrophonium—Abdominal pain—Doxorubicin—ovarian cancer	0.00157	0.00327	CcSEcCtD
Edrophonium—Asthenia—Epirubicin—ovarian cancer	0.00154	0.00321	CcSEcCtD
Edrophonium—Diarrhoea—Epirubicin—ovarian cancer	0.00147	0.00306	CcSEcCtD
Edrophonium—Asthenia—Doxorubicin—ovarian cancer	0.00143	0.00297	CcSEcCtD
Edrophonium—Vomiting—Epirubicin—ovarian cancer	0.00137	0.00284	CcSEcCtD
Edrophonium—Diarrhoea—Doxorubicin—ovarian cancer	0.00136	0.00283	CcSEcCtD
Edrophonium—Nausea—Epirubicin—ovarian cancer	0.00128	0.00265	CcSEcCtD
Edrophonium—Vomiting—Doxorubicin—ovarian cancer	0.00127	0.00263	CcSEcCtD
Edrophonium—Nausea—Doxorubicin—ovarian cancer	0.00118	0.00246	CcSEcCtD
